United States Peptide Therapeutics Market Report 2016

November 2016 | 105 pages | ID: U487BB16E84EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Peptide Therapeutics

Revenue, means the sales value of Peptide Therapeutics

This report studies sales (consumption) of Peptide Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• Roche
• Sanofi
• Takeda Pharmaceutical
• Lonza
• Novartis
• AstraZeneca
• Bachem
• CordenPharma
• Eli Lilly
• Ipsen
• Merck
• Novo Nordisk
• PolyPeptide Group
• Teva

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Generic Peptide Therapeutics
• Branded Peptide Therapeutics
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Peptide Therapeutics in each application, can be divided into

• Cancer
• Cardiovascular
• Central Nervous System
• Metabolic Disorders
• Infection
• Hematological Disorders
• Gastrointestinal Disorders
• Respiratory Disorders
• Acromegaly
• Other Applications

Contents

United States Peptide Therapeutics Market Report 2016

1 PEPTIDE THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
  1.2.1 Generic Peptide Therapeutics
  1.2.2 Branded Peptide Therapeutics
  1.2.3 Type III
1.3 Application of Peptide Therapeutics
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 Central Nervous System
  1.3.4 Metabolic Disorders
  1.3.5 Infection
  1.3.6 Hematological Disorders
  1.3.7 Gastrointestinal Disorders
  1.3.8 Respiratory Disorders
  1.3.9 Acromegaly
  1.3.10 Other Applications
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Peptide Therapeutics (2011-2021)
  1.4.1 United States Peptide Therapeutics Sales and Growth Rate (2011-2021)
  1.4.2 United States Peptide Therapeutics Revenue and Growth Rate (2011-2021)

2 UNITED STATES PEPTIDE THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Peptide Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Peptide Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Peptide Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Peptide Therapeutics Market Competitive Situation and Trends
  2.4.1 Peptide Therapeutics Market Concentration Rate
  2.4.2 Peptide Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PEPTIDE THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Peptide Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Peptide Therapeutics Price by Type (2011-2016)
3.4 United States Peptide Therapeutics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PEPTIDE THERAPEUTICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Peptide Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Peptide Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PEPTIDE THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Amgen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Peptide Therapeutics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Roche
  5.2.2 Peptide Therapeutics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Peptide Therapeutics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Takeda Pharmaceutical
  5.4.2 Peptide Therapeutics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Lonza
  5.5.2 Peptide Therapeutics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Lonza Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis
  5.6.2 Peptide Therapeutics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 AstraZeneca
  5.7.2 Peptide Therapeutics Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bachem
  5.8.2 Peptide Therapeutics Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bachem Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 CordenPharma
  5.9.2 Peptide Therapeutics Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 CordenPharma Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Eli Lilly
  5.10.2 Peptide Therapeutics Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Ipsen
5.12 Merck
5.13 Novo Nordisk
5.14 PolyPeptide Group
5.15 Teva

6 PEPTIDE THERAPEUTICS MANUFACTURING COST ANALYSIS

6.1 Peptide Therapeutics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Peptide Therapeutics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Peptide Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PEPTIDE THERAPEUTICS MARKET FORECAST (2016-2021)

10.1 United States Peptide Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Peptide Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Peptide Therapeutics Sales Forecast by Application (2016-2021)
10.4 Peptide Therapeutics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure United States Sales Market Share of Peptide Therapeutics by Type in 2015
Figure Generic Peptide Therapeutics Picture
Figure Branded Peptide Therapeutics Picture
Table Application of Peptide Therapeutics
Figure United States Sales Market Share of Peptide Therapeutics by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure Central Nervous System Examples
Figure Metabolic Disorders Examples
Figure Infection Examples
Figure Hematological Disorders Examples
Figure Gastrointestinal Disorders Examples
Figure Respiratory Disorders Examples
Figure Acromegaly Examples
Figure Other Applications Examples
Figure United States Peptide Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Peptide Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Peptide Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Peptide Therapeutics Sales Share by Manufacturers
Figure 2016 Peptide Therapeutics Sales Share by Manufacturers
Table United States Peptide Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Peptide Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Peptide Therapeutics Revenue Share by Manufacturers
Table 2016 United States Peptide Therapeutics Revenue Share by Manufacturers
Table United States Market Peptide Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Peptide Therapeutics Average Price of Key Manufacturers in 2015
Figure Peptide Therapeutics Market Share of Top 3 Manufacturers
Figure Peptide Therapeutics Market Share of Top 5 Manufacturers
Table United States Peptide Therapeutics Sales by Type (2011-2016)
Table United States Peptide Therapeutics Sales Share by Type (2011-2016)
Figure United States Peptide Therapeutics Sales Market Share by Type in 2015
Table United States Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Peptide Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Peptide Therapeutics by Type (2011-2016)
Table United States Peptide Therapeutics Price by Type (2011-2016)
Figure United States Peptide Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Peptide Therapeutics Sales by Application (2011-2016)
Table United States Peptide Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Peptide Therapeutics Sales Market Share by Application in 2015
Table United States Peptide Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Peptide Therapeutics Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Peptide Therapeutics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Peptide Therapeutics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Peptide Therapeutics Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Peptide Therapeutics Sales Market Share (2011-2016)
Table Lonza Basic Information List
Table Lonza Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Peptide Therapeutics Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Peptide Therapeutics Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Peptide Therapeutics Sales Market Share (2011-2016)
Table Bachem Basic Information List
Table Bachem Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bachem Peptide Therapeutics Sales Market Share (2011-2016)
Table CordenPharma Basic Information List
Table CordenPharma Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CordenPharma Peptide Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Peptide Therapeutics Sales Market Share (2011-2016)
Table Ipsen Basic Information List
Table Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ipsen Peptide Therapeutics Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Peptide Therapeutics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Peptide Therapeutics Sales Market Share (2011-2016)
Table PolyPeptide Group Basic Information List
Table PolyPeptide Group Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table PolyPeptide Group Peptide Therapeutics Sales Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Peptide Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Therapeutics
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Peptide Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
Table Major Buyers of Peptide Therapeutics
Table Distributors/Traders List
Figure United States Peptide Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Peptide Therapeutics Production Forecast by Type (2016-2021)
Table United States Peptide Therapeutics Consumption Forecast by Application (2016-2021)